Agenda

EXPANDING THE SCOPE OF INTRACRANIAL HEMORRHAGE (ICH), CEREBRAL VENOUS DISEASE (CVD) AND
INTRACRANIAL ATHEROOCCLUSIVE DISEASE
(ICAD) TREATMENT

New Perspectives on Epidemiology, Clinical Trials,

Patient Selection, Evolving Therapies, and Pre-clinical System Models

  7:00 – 8:00 am

FULL BREAKFAST PROVIDED

Location: TBA

  8:00 – 8:15 am

ACADEMIA/INDUSTRY/FDA/NIH ROUNDTABLE ON ICH, CVD AND ICAD – OBJECTIVES

Location: TBA

Chairs: Ajay Wakhloo, TUFTS University School of Medicine, USA
Adam Arthur, University of Tennessee, USA

 Introduction: Marc Fisher, BIDMC/Harvard Medical School, USA

  8:15 – 11:00 am

SESSION 1: INTRACEREBRAL HEMORRHAGE (ICH) – NEW DATA, NEW LANDSCAPE, NEW APROACHES

Location: TBA

Chairs: Mark Bain, Cleveland Clinic, USA
Christopher Kellner,Mount Sinai, USA

8:15 8:35
INTRACEREBRAL HEMORRHAGE EPIDEMIOLOGY
8:15- 8:27 Presentation by Juhana Frösen, Tampere University and University Hospital Tampere, Finland
8:27 -8:35 Comments by Jan- Karl Burkhardt, University of Pennsylvania, USA

8:35 8:55
MAJOR ICH CLINICAL TRIALS
8:35 – 8:47 Presentation by Gustavo Pradilla, Emory University, USA
8:47 – 8:55 Comments by David Fiorella, Stony Brook University, USA

8:55 9:15
CURRENT MIS EVACUATION TECHNIQUES
8:55 – 9:07 Presentation by Christopher Kellner, Mount Sinai, USA
9:07 – 9:15 Comments by Brian Jankowitz, JFK University Medical Center
Edison, USA

9:15 9:35
NOVEL TECHNOLOGIES
9:15 – 9:27 Presentation by Mark Bain, Cleveland Clinic, USA
9:27 – 9:35 Comments by J Mocco, Mount Sinai Health System, USA

09:35 – 11:00 ROUNDTABLE PANEL DISCUSSION
Panelists:
Mark Bain
, Cleveland Clinic, USA; Christopehr Kellner, Mount Sinai, USA; J Mocco, Mount Sinai Health System, USA; David Fiorella, Stony Brook University, USA; Jan- Karl Burkhardt, University of Pennsylvania, USA; Juhana Frösen, Tampere University and University Hospital Tampere, Finland; Babu Welch, UT Southwestern Medical Center, USA; Nagesh Uppuluri, MicroVention, USA

  11:00 – 11:15 am

REFRESHMENT BREAK

Location: TBA

  11:15 am– 1:30 pm

SESSION 2: CEREBRAL VENOUS DISEASES: NEW DATA, NEW LANDSCAPE, NEW APROACHES

Location: TBA

Chairs: Vitor Pereira, University of Toronto and St. Michael’s Hospital, Canada
TBA

11:15 11:35
OVERVIEW OF CEREBRAL VENOPATHIES
11:15 – 11:27 Presentation by TBA
11:27 – 11:35 Comments by Dorothea Altschul, The Valley Hospital, USA

11:35 11:55
CEREBRAL PHLEBOGRAPHY – WHAT SHOULD WE BE LOOKING FOR?
11:35 – 11:47 Presentation by Omar Choudhri, University of Pennsylvania, USA
11:47 – 11:53 Comments by Ferdinand Hui, University of Hawai, USA

11:55- 12:15
CEREBRAL VENOPATHIES – MANAGEMENT OPTIONS
11:55 – 12:07 Presentation by Vitor Pereira, University of Toronto and St. Michael’s Hospital, Canada
12:07 – 12:15 Comments by Peter Kan, The University of Texas Medical Branch, USA

12:15 – 12:35
CLINICAL TRIAL DESIGNS – WHAT IS NEXT?
12:15 – 12:27 Presentation by Kyle Fargen, Atrium Health Wake Forest Baptist Medical Center, USA
12:27 – 12:35 Comments by Athos Patsalides, North Shore University Hospital, USA

12:35 – 1:30
ROUNDTABLE PANEL DISCUSSION
Panelists:
Vitor Pereira
, University of Toronto and St. Michael’s Hospital, Canada;  Gabor Toth, Cleveland Clinic, USA; David Liebeskind, UCLA, USA; Pierre Gobin, Cornell University, USA; Athos Patsalides, North Shore University Hospital, USA; Ferdinand Hui, University of Hawai; John Daniel, Stryker, USA; Richard Benson, NIH, USA

 

  1:30 – 2:30 pm

LUNCH PROVED

Location: TBA

  2:30 – 5:00 pm

SESSION 3: INTRACRANIAL ATHEROCCLUSIVE DISEASE (ICAD): NEW DATA, NEW LANDSCAPE, NEW APROACHES

Location: TBA

Chairs: Brian Hoh, University of Florida, USA
Raul Nogueira, University of Pittsburgh, USA

2:30 – 2:50 DO WE KNOW MORE AFTER SAMMPRIS/VISSIT WHAT WENT RIGHT, WHAT WENT WRONG?
2:30 – 2:42 Presentation by Sam Zaidat, Mercy Health St Vincent, USA
2:42 – 2:50 Comments by Raul Nogueira, University of Pittsburgh, USA

2:50 – 3:10 ROLE OF SURGERY IN ICAD
2:50 – 3:02 Presentation by Sepideh Amin-Hanjani, University Hospitals Cleveland Medical Center, USA
3:02 – 3:10 Comments by Fady Charbel, University of Illinois at Chicago College of Medicine, USA

3:10 3:30
ENDOVASCULAR MANAGEMENT OF ICAD
3:10 – 3:22 Presentation by Pedro Lylyk, University of Buenos Aires, USA
3:22 – 3:30 Comments by Demetrius Lopes, Advocate Aurora Health, USA

3:30 3:50
IMAGING OF ICAD
3:30 – 3:42 Presentation by Matthew J Gounis, UMass Chan Medical School, USA
3:42 – 3:50 Comments by Edgar Samaniego, University of Iowa, Iowa City, USA

3:50-4:10 MODERN MANAGEMENT OF ICAD – WHAT WE KNOW AND WHAT WE MUST LEARN
3:50 – 4:02 Presentation by Brian Hoh, University of Florida, USA
4:02 – 4:10 Comments by Fawaz Al-Mufti, New York Medical College, USA

4:10 – 5:00 ROUNDTABLE PANEL DISCUSSION
Panelists:
Brian Hoh
, University of Florida, USA; Raul Nogueira, University of Pittsburgh, USA; Sepideh Amin-Hanjani, University Hospitals Cleveland Medical Center, USA; Fawaz Al-Mufti, New York Medical College, USA; Satoshi Tateshima, UCLA, USA; Italo Linfante, Miami Neuroscience Institute, USA; Ali Sultan, Harvard Medical School, USA; Geoffrey Colby, University of California, USA; Jennifer Mateus, Stryker, USA; Clinton Wright, NIH, USA; Fady Charbel, University of Illinois at Chicago College of Medicine, USA

  5:00 – 5:15 pm

REFRESHMENT BREAK

Location: TBA

  5:15 – 6:15 pm

SESSION 4: REGULATORY PERSPECTIVE ON KEY CLINICAL TRIAL ISSUES

Location: TBA

Chairs: Adnan Siddiqui, State University of New York, USA;
Ricardo Hanel, Baptist Health, USA;
Xiaolin (Lin) Zheng, FDA, USA

5:15–5:35 FROM BENCH TO FIRST-IN-HUMAN: WHAT IS NEEDED FOR AN EARLY FEASIBILITY STUDY IDE?
Xiaolin (Lin) Zheng, FDA, USA

  • Understanding the transition from bench research to the initial stages of human trials.
  • Identifying the critical elements required to initiate Early Feasibility Study IDEs in the U.S.
  • FDA Panel (CDER & CDRH) Answers to Stroke Community Questions

5:35 – 6:15
ROUNDTABLE PANEL DISCUSSION
Panelists:
Adnan Siddiqui
, State University of New York, USA; Philipp Taussky, BIDMC/Harvard Medical School, USA; Ricardo Hanel, Baptist Health, USA; Guilherme Dabus, Miami Cardiac and Vascular Institute and Baptist Neuroscience Institute, USA; David Altschul, Montefiore Medical Center, USA; Adel Malek, Tufts Medical Center, USA; Xiaolin (Lin) Zheng, FDA, USA; Gabriela Suarez-Mier, FDA, USA; Amy Smith, MicroVention, USA

  6:30 – 9:30 pm

EVENING OF NETWORKING: BUILDING CONNECTIONS AND OPPORTUNITIES FOLLOWED BY SPECIAL PRESENTATION

Location: West End Hall

Introduction: Adam Arthur, University of Tennessee, USA
Ajay Wakhloo
, TUFTS University School of Medicine, USA

BIOINSPIRED BREAKTHROUGHS IN MEDICINE: FROM SHEAR-TARGETED STROKE THERAPEUTICS TO HUMAN ORGAN CHIPS
Donald E. Ingber,
Harvard University, USA

  7:00 – 8:00 am

FULL BREAKFAST PROVIDED

Location: TBA

  8:00 – 10:45 am

WORKSHOPS TO DEVELOP CONSENSUS RECOMMENDATIONS

Participants are divided into three groups – each to develop recommendations for planned publication in a major scientific journal.

Location: TBA

Workshop #1
MOST PROMISING APPROACHES TO IMPROVE THE TREATMENT OF INTRACRANIAL HEMORRHAGE
Moderators: Vitor Pereira, University of Toronto and St. Michael’s Hospital, Canada
Ferdinand Hui, University of Hawai, USA
Matthew Amans, University of California, USA

Location: TBA

Workshop #2
MOST PROMISING APPROACHES TO IMPROVE THE TREATMENT OF CEREBRAL VENOUS DISEASES

Moderators: Mark Bain, Cleveland Clinic, USA
Christopher Kellner, Mount Sinai, USA
Ricardo Hanel, Baptist Health, USA

Location: TBA

Workshop #3
MOST PROMISING APPROACHES TO IMPROVE THE TREATMENT OF INTRACRANIAL ATHEROOCCLUSIVE DISEASE
Moderators: Brian Hoh,
University of Florida, USA
Stavropoula Tjoumakaris,
Thomas Jefferson University, USA
Guilherme Dabus,
Miami Cardiac and Vascular Institute and Baptist Neuroscience Institute, USA

  10:45 – 11:00 am

REFRESHMENT BREAK

Location: TBA

  11:00 am – 12:00 pm

WORKSHOP CHAIRS PRESENT RECOMMENDATIONS TO FULL ASSEMBLY

Drafting of consensus statement is initiated

Chaired by Adam Arthur, University of Tennessee, USA
Ajay K Wakhloo, TUFTS University School of Medicine, USA

  12:00 – 12:15 pm

CLOSING COMMENTS AND ADJOURNMENT